Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Accumulated Expenses: 2020-2024

Historic Accumulated Expenses for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to $17.4 million.

  • Journey Medical's Accumulated Expenses rose 32.39% to $21.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.2 million, marking a year-over-year increase of 32.39%. This contributed to the annual value of $17.4 million for FY2024, which is 14.37% down from last year.
  • As of FY2024, Journey Medical's Accumulated Expenses stood at $17.4 million, which was down 14.37% from $20.4 million recorded in FY2023.
  • Journey Medical's 5-year Accumulated Expenses high stood at $22.7 million for FY2021, and its period low was $17.4 million during FY2024.
  • Moreover, its 3-year median value for Accumulated Expenses was $19.4 million (2022), whereas its average is $19.1 million.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first grew by 5.74% in 2021, then dropped by 14.71% in 2022.
  • Over the past 5 years, Journey Medical's Accumulated Expenses (Yearly) stood at $21.5 million in 2020, then grew by 5.74% to $22.7 million in 2021, then dropped by 14.71% to $19.4 million in 2022, then rose by 4.96% to $20.4 million in 2023, then dropped by 14.37% to $17.4 million in 2024.